Revolution Medicines Correlations

RVMD Stock

USD 57.85 0.73 1.25%

The current 90-days correlation between Revolution Medicines and Blueprint Medicines Corp is 0.32 (i.e., Weak diversification). The correlation of Revolution Medicines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Revolution Medicines Correlation With Market

Weak diversification

The correlation between Revolution Medicines and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revolution Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.

Moving together with Revolution Stock

0.74	VTRS	Viatris	Pair Corr
0.85	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.77	EWTX	Edgewise Therapeutics	Pair Corr
0.74	BHC	Bausch Health Companies	Pair Corr
0.92	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.72	EBS	Emergent Biosolutions	Pair Corr
0.79	WAT	Waters	Pair Corr
0.91	GILD	Gilead Sciences	Pair Corr
0.76	MNMD	Mind Medicine	Pair Corr
0.82	CPRX	Catalyst Pharmaceuticals	Pair Corr

Moving against Revolution Stock

0.9	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.87	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.86	HLN	Haleon plc	Pair Corr
0.86	RDY	Dr Reddys Laboratories	Pair Corr
0.84	LLY	Eli Lilly	Pair Corr
0.83	TAK	Takeda Pharmaceutical	Pair Corr
0.79	ZTS	Zoetis Inc	Pair Corr
0.77	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.65	LTRN	Lantern Pharma	Pair Corr
0.49	ELAN	Elanco Animal Health	Pair Corr
0.79	ANRO	Alto Neuroscience,	Pair Corr
0.69	AMGN	Amgen Inc	Pair Corr
0.63	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.55	TEVA	Teva Pharma Industries	Pair Corr
0.47	SIGA	SIGA Technologies	Pair Corr
0.46	ABBV	AbbVie Inc Sell-off Trend	Pair Corr
0.42	MDT	Medtronic PLC	Pair Corr
0.32	REVB	Revelation Biosciences	Pair Corr
0.31	DRMAW	Dermata Therapeutics	Pair Corr

Related Correlations Analysis

	BPMC	SANA	KYMR	GLUE	TCRR	BDTX	BCEL	PASG	AKRO	RNA
BPMC		-0.36	0.2	0.61	0.23	-0.17	-0.36	0.03	0.54	0.16	BPMC
SANA	-0.36		0.11	-0.61	-0.67	0.86	-0.07	0.35	-0.71	-0.27	SANA
KYMR	0.2	0.11		0.19	0.12	0.15	0.09	0.25	0.23	0.2	KYMR
GLUE	0.61	-0.61	0.19		0.59	-0.46	-0.38	0.06	0.69	0.01	GLUE
TCRR	0.23	-0.67	0.12	0.59		-0.68	-0.08	-0.44	0.72	0.32	TCRR
BDTX	-0.17	0.86	0.15	-0.46	-0.68		-0.23	0.48	-0.76	-0.43	BDTX
BCEL	-0.36	-0.07	0.09	-0.38	-0.08	-0.23		-0.04	0.05	0.47	BCEL
PASG	0.03	0.35	0.25	0.06	-0.44	0.48	-0.04		-0.25	-0.3	PASG
AKRO	0.54	-0.71	0.23	0.69	0.72	-0.76	0.05	-0.25		0.47	AKRO
RNA	0.16	-0.27	0.2	0.01	0.32	-0.43	0.47	-0.3	0.47		RNA
	BPMC	SANA	KYMR	GLUE	TCRR	BDTX	BCEL	PASG	AKRO	RNA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BDTX	+ 0.86	SANA
AKRO	+ 0.72	TCRR
AKRO	+ 0.69	GLUE
GLUE	+ 0.61	BPMC
TCRR	+ 0.59	GLUE
AKRO	+ 0.54	BPMC

High negative correlations

AKRO	- 0.76	BDTX
AKRO	- 0.71	SANA
BDTX	- 0.68	TCRR
TCRR	- 0.67	SANA
GLUE	- 0.61	SANA
BDTX	- 0.46	GLUE

Risk-Adjusted Indicators

There is a big difference between Revolution Stock performing well and Revolution Medicines Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Revolution Medicines' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BPMC	1.82	(0.08)	(0.02)	0.06	2.57	(1.71)	4.90	(3.62)	14.28
SANA	3.55	(1.23)	0.00	(0.63)	0.00	0.00	7.69	(8.07)	23.40
KYMR	2.36	(0.27)	0.00	(0.01)	0.00	0.00	4.84	(4.74)	18.10
GLUE	5.18	0.88	0.25	0.43	3.74	(7.01)	8.10	(8.18)	102.66
TCRR	3.16	0.36	0.06	3.03	3.26	(4.40)	5.77	(6.25)	43.60
BDTX	3.55	(1.52)	0.00	(0.56)	0.00	0.00	5.47	(8.30)	19.51
BCEL	3.90	0.14	0.01	0.46	5.00	(4.64)	7.53	(9.65)	23.80
PASG	6.16	0.76	0.15	0.37	5.91	(7.95)	12.07	(10.45)	32.24
AKRO	2.37	0.09	0.07	0.17	2.62	(2.49)	5.23	(4.45)	13.37
RNA	2.92	(0.17)	(0.02)	0.03	4.30	(2.99)	5.78	(7.08)	27.94

Revolution Medicines Corporate Management

David Pompliano	Founding Officer	Profile
Jack Anders	Chief Officer	Profile
Erin Graves	Senior Relations	Profile
Walter Reiher	Chief Officer	Profile
Path FRCP	Pres RD	Profile
Margaret JD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC